as Nuvilex. Moving our discoveries into the world takes resources - investment capital, which has all but disappeared from the market because of the current economic downturn. If Citroxin takes root as envisioned, demand will outpace our manufacturing capabilities and it will be necessary for us to seek a commercial partner to move the product quickly into the marketplace."
Citroxin is a eco-friendly surface cleaner. The Company's viral testing to date has been led by Sagar M. Goyal, D.V.M., Ph.D. at the University of Minnesota. Dr. Goyal has investigated the use of Citroxin to treat viral subtypes of SIV (H1N1). In Dr. Goyal's first experiment, his team evaluated the ability of Citroxin (dilutions of 1:10 and 1:100) to inhibit the replication of SIV H1N1 in vitro. Compared to the controls, high concentrations of Citroxin (1:10 dilution) were found to be virucidal for SIV growing in MDCK (Madin-Darby canine kidney) cells.
The Company, in conjunction with international based academic researchers, has also treated H9N9 AIV with Citroxin. In the AIV H9N9 experiments, Citroxin also served as a better virucidal agent when it received a smaller viral challenge (1000, 100, and 10 tissue culture infectious dose50, or TCID50, of virus).
"Although Citroxin is not yet proven to be immunogenic, experiments do suggest that Citroxin can serve as an effective cleaner or disinfectant for surfaces that may have come into contact with SIV, AIV, or other types of virus particles," said Dr. Morello. "We are ready, willing and able to help the global public health community in combating the swine flu outbreak."
About Nuvilex, Inc.
Nuvilex, formerly eFoodSafety.com, Inc. is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare pPage: 1 2 3 4 Related medicine news :1
. Nuvilex, Inc. Announces Investor Conference Call and Open House2
. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May3
. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign4
. Nuvilex Provides Conference Call Replay Information5
. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group6
. Nuvilex Infinitink Tattoo Ink Featured on PBS alt.news 26:46 TV Program7
. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company8
. New advances in cancer research to be highlighted at University of Leicester9
. Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances10
. Survey Results: Health Care Technology Advances as Physician Frustration Grows11
. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials